The Only Sealant Designed Specifically for Thoracic Surgeons Now Offers Even Better Access  IRVINE, Calif. – Neomend, Inc., a leading innovator in sealant and adhesion-prevention products for the surgical marketplace, said it has received premarket approval (PMA) from the U.S. Food and Drug Administration for use of the company’s new Progel® Extended Applicator Spray Tip. [...]

IRVINE, Calif. – Neomend, Inc., a leading innovator in sealant and adhesion-prevention products for the surgical marketplace, announced it has received the European Union CE Mark for the company’s Progel® Adhesion Barrier (AB) product.  Progel® AB is a hydrogel adhesion barrier sealant that can be sprayed onto general visceral organs during surgery to help prevent [...]

Neomend is pleased to participate in the 48th Annual Meeting of The Society of Thoracic Surgeons January 29 – February 1 in Fort Lauderdale, FL. Visit us at Booth # 103 to see what’s new at Neomend!

IRVINE, Calif. – Neomend, Inc., has been awarded the European Union CE Mark for its Progel® Platinum Surgical Sealant. The company is an innovator in sealant and adhesion-prevention products for the surgical market. “Receipt of the CE Mark positions Neomend to substantially grow its revenue on a worldwide basis,” said David Renzi, the company’s President [...]

IRVINE, California –  Neomend, Inc., an innovator in sealant and adhesion-prevention products for the surgical marketplace, announced today it has completed a funding round of $30 million, with Clarus Ventures, LLC investing $17 million. Also joining the Series D funding round were the other major investors in Neomend: Sanderling Ventures, Novo Ventures, Vivo Ventures, and [...]